NGeneBio has signed a service contract with Chonnam National University Hwasun Hospital(CNUHH) to build a ‘cloud-based genome analysis platform’ to support clinical data analysis and precision medicine service development.
This service contract is part of the Korea Ministry of Trade, Industry, and Energy’s “A public project to establish a platform to support advanced precision medicine industrialization”. The clinical genome analysis platform planned and built by NGeneBio analyzes data using NGS technology and artificial intelligence for vast amounts of cancer data accumulated by Hwasun Chonnam National University Hospital for 17 years.
Through the clinical genome analysis platform, Hwasun Chonnam National University Hospital plans to promote ▲ customized cancer diagnosis treatment ▲ customized precision medicine service ▲industrialization of medical devices based on AI.
For the full Korean press release, head over to the below link.
September 8, 2021 @South Korea